63 related articles for article (PubMed ID: 3365359)
1. Lysis of human immunodeficiency virus infected cells by TPA-type and non-TPA type tumor promoters.
Harada S; Yamamoto N; Fujiki H
AIDS Res Hum Retroviruses; 1988 Apr; 4(2):99-105. PubMed ID: 3365359
[TBL] [Abstract][Full Text] [Related]
2. Synergistic stimulation of histamine release from rat peritoneal mast cells by 12-O-tetradecanoylphorbol 13-acetate (TPA)-type and non-TPA-type tumor promoters.
Ohuchi K; Hirasawa N; Takahashi C; Watanabe M; Tsurufuji S; Fujiki H; Suganuma M; Hakii H; Sugimura T; Christensen SB
Biochim Biophys Acta; 1986 Jun; 887(1):94-9. PubMed ID: 2423139
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of prostaglandin E2 production by 12-O-tetradecanoylphorbol 13-acetate (TPA)-type and non-TPA-type tumor promoters in macrophages and its inhibition by cycloheximide.
Ohuchi K; Watanabe M; Yoshizawa K; Tsurufuji S; Fujiki H; Suganuma M; Sugimura T; Levine L
Biochim Biophys Acta; 1985 Mar; 834(1):42-7. PubMed ID: 2858221
[TBL] [Abstract][Full Text] [Related]
4. [The actions of TPA-type as well as non-TPA type tumor promoters and their mechanism(s) in tumor promotion].
Fujiki H
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):758-65. PubMed ID: 2870684
[TBL] [Abstract][Full Text] [Related]
5. Tumor promoter, TPA, enhances replication of HTLV-III/LAV.
Harada S; Koyanagi Y; Nakashima H; Kobayashi N; Yamamoto N
Virology; 1986 Oct; 154(2):249-58. PubMed ID: 3639669
[TBL] [Abstract][Full Text] [Related]
6. Augmentation of cytotoxic effect of tumor necrosis factor on human immunodeficiency virus-infected cells by staurosporine, a potent protein kinase C inhibitor.
Hamamoto Y; Matsuyama T; Yamamoto N; Kobayashi N
Cancer Res; 1990 Sep; 50(17):5287-90. PubMed ID: 2386936
[TBL] [Abstract][Full Text] [Related]
7. The phorbol ester TPA strongly inhibits HIV-1-induced syncytia formation but enhances virus production: possible involvement of protein kinase C pathway.
Chowdhury IH; Koyanagi Y; Kobayashi S; Hamamoto Y; Yoshiyama H; Yoshida T; Yamamoto N
Virology; 1990 May; 176(1):126-32. PubMed ID: 1970444
[TBL] [Abstract][Full Text] [Related]
8. Platelet-activating factor stimulates arachidonic acid metabolism in rat liver cells (C-9 cell line) by a receptor-mediated mechanism.
Levine L
Mol Pharmacol; 1988 Dec; 34(6):793-9. PubMed ID: 2849046
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of primate retrovirus synthesis by tumour promoters.
Wunderlich V; Sydow G; Baumbach L
IARC Sci Publ; 1984; (56):299-304. PubMed ID: 6443105
[TBL] [Abstract][Full Text] [Related]
10. Activation of stress-activator protein kinase/c-Jun N-terminal kinase by the non-TPA-type tumor promoter palytoxin.
Kuroki DW; Bignami GS; Wattenberg EV
Cancer Res; 1996 Feb; 56(3):637-44. PubMed ID: 8564984
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of arachidonic acid metabolism by different types of tumor promoters.
Levine L; Fujiki H
Carcinogenesis; 1985 Nov; 6(11):1631-4. PubMed ID: 2865014
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of superoxide anion formation by the non-TPA type tumor promoters palytoxin and thapsigargin in porcine and human neutrophils.
Kano S; Iizuka T; Ishimura Y; Fujiki H; Sugimura T
Biochem Biophys Res Commun; 1987 Mar; 143(2):672-7. PubMed ID: 2882751
[TBL] [Abstract][Full Text] [Related]
13. Effects of various tumor promoters on expression of cartilage phenotypes in rabbit costal chondrocytes in culture.
Takigawa M; Tajima K; Fukuo K; Fujiki H; Suzuki F
J Biochem; 1987 Feb; 101(2):397-404. PubMed ID: 2438271
[TBL] [Abstract][Full Text] [Related]
14. Substances affecting the infection and replication of human immunodeficiency virus (HIV).
Yamamoto N; Harada S; Nakashima H
AIDS Res; 1986 Dec; 2 Suppl 1():S183-9. PubMed ID: 3030346
[TBL] [Abstract][Full Text] [Related]
15. Tumor promoters alter the temporal program of adenovirus replication in human cells.
Fisher PB; Young CS; Weinstein IB; Carter TH
Mol Cell Biol; 1981 Apr; 1(4):370-80. PubMed ID: 6965103
[TBL] [Abstract][Full Text] [Related]
16. Effect of culture supernatant of MT-2 cells on human immunodeficiency virus-producing cells, MOLT-4/HIVHTLV-IIIB cells.
Matsuyama T; Hamamoto Y; Yoshida T; Kido Y; Kobayashi S; Kobayashi N; Yamamoto N
Jpn J Cancer Res; 1988 Feb; 79(2):156-9. PubMed ID: 3130348
[TBL] [Abstract][Full Text] [Related]
17. Nakahara memorial lecture. New classes of tumor promoters: teleocidin, aplysiatoxin, and palytoxin.
Fujiki H; Suganuma M; Tahira T; Yoshioka A; Nakayasu M; Endo Y; Shudo K; Takayama S; Moore RE; Sugimura T
Princess Takamatsu Symp; 1983; 14():37-45. PubMed ID: 6151565
[TBL] [Abstract][Full Text] [Related]
18. Sulfation of polysaccharides generates potent and selective inhibitors of human immunodeficiency virus infection and replication in vitro.
Nakashima H; Yoshida O; Tochikura TS; Yoshida T; Mimura T; Kido Y; Motoki Y; Kaneko Y; Uryu T; Yamamoto N
Jpn J Cancer Res; 1987 Nov; 78(11):1164-8. PubMed ID: 2447045
[TBL] [Abstract][Full Text] [Related]
19. Heterologous regulation of the epidermal growth factor receptor by palytoxin, a non-12-O-tetradecanoylphorbol-13-acetate-type tumor promoter.
Wattenberg EV; Fujiki H; Rosner MR
Cancer Res; 1987 Sep; 47(17):4618-22. PubMed ID: 2887282
[TBL] [Abstract][Full Text] [Related]
20. Two tumor promoters, 12-O-tetradecanoylphorbol-13-acetate and thapsigargin, act synergistically via distinct signaling pathways to stimulate gene expression.
Lenormand P; Muldoon LL; Enslen H; Rodland KD; Magun BE
Cell Growth Differ; 1990 Dec; 1(12):627-35. PubMed ID: 2126950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
